乳腺癌患者手术时间的长度增加:一项全国性队列研究
Gabriella N Tortorello1, Neha Shafique2, Luke Keele2
1Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Gabriella.tortorello@pennmedicine.upenn.edu.
Annals of surgical oncology
|July 13, 2024
概括
尽管已知存活风险,但乳腺癌手术的时间增加了,尤其影响到边缘化群体. 这种趋势需要紧急干预,以确保公平及时的患者护理.
科学领域:
- 在瘤学瘤学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 手术时间较长 (TTS) 与乳腺癌患者的生存结果较差有关.
- 目前尚不清楚这种关联是否导致了护理交付的提升.
研究的目的:
- 在国家癌症数据库中分析乳腺癌患者的手术时间 (TTS) 的趋势.
- 调查TTS是否随着时间的推移增加或减少,并确定与长期TTS相关的因素.
主要方法:
- 利用国家癌症数据库 (2006-2019) 对诊断为临床阶段0-III乳腺癌的患者进行手术作为第一疗法.
- 采用线性逐线性趋势测试和调整的线性回归建模来评估TTS趋势和子组变化.
主要成果:
- 分析了超过140万名患者;中位数TTS从2006年的26天增加到2019年的39天 (p < 0.001).
- 观察到TTS每年平均增加0.83天 (p < 0.001).
- 长期的TTS与黑人种族,西班牙裔种族,医疗补助保险,无保险状态,乳腺切除和重建性手术有显著的关联.
结论:
- 乳腺癌手术的时间稳步增加,尽管有证据将更长的延迟与不良结果联系起来.
- 这种不断增加的TTS可能会不成比例地伤害边缘化的患者群体.
- 进一步的研究和干预至关重要,以保证所有乳腺癌患者的及时和公平的护理.
更多相关视频
06:03Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
6.6K
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
2.6K
相关概念视频
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
01:21Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340